Business Description
Orion Pharma Ltd
ISIN : BD0486OPL004
Compare
Compare
Traded in other countries / regions
ORIONPHARM.Bangladesh IPO Date
2013-03-20Description
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.03 | |||||
| Debt-to-EBITDA | 17.87 | |||||
| Interest Coverage | 3.96 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.98 | |||||
| Beneish M-Score | -2.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.1 | |||||
| 3-Year EBITDA Growth Rate | -13.6 | |||||
| 3-Year EPS without NRI Growth Rate | -1.2 | |||||
| 3-Year Book Growth Rate | 5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.01 | |||||
| 9-Day RSI | 64.01 | |||||
| 14-Day RSI | 60.21 | |||||
| 6-1 Month Momentum % | -19.1 | |||||
| 12-1 Month Momentum % | -19.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.86 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 77.67 | |||||
| Days Sales Outstanding | 169.57 | |||||
| Days Payable | 246.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.34 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| 3-Year Dividend Growth Rate | -12.6 | |||||
| Forward Dividend Yield % | 1.34 | |||||
| 5-Year Yield-on-Cost % | 0.86 | |||||
| Shareholder Yield % | -7.41 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.9 | |||||
| Operating Margin % | 5.8 | |||||
| Net Margin % | 3.96 | |||||
| FCF Margin % | -10.62 | |||||
| ROE % | 2.17 | |||||
| ROA % | 0.85 | |||||
| ROIC % | 1.18 | |||||
| ROC (Joel Greenblatt) % | 2.64 | |||||
| ROCE % | 1.68 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 38.44 | |||||
| PE Ratio without NRI | 38.46 | |||||
| Shiller PE Ratio | 17.12 | |||||
| PS Ratio | 1.52 | |||||
| PB Ratio | 0.8 | |||||
| Price-to-Tangible-Book | 0.8 | |||||
| Price-to-Operating-Cash-Flow | 10.84 | |||||
| EV-to-EBIT | 54.8 | |||||
| EV-to-EBITDA | 31.67 | |||||
| EV-to-Revenue | 3.44 | |||||
| EV-to-FCF | -31.48 | |||||
| Price-to-Projected-FCF | 1.83 | |||||
| Price-to-Graham-Number | 1.17 | |||||
| Earnings Yield (Greenblatt) % | 1.83 | |||||
| FCF Yield % | -6.98 | |||||
| Forward Rate of Return (Yacktman) % | -10.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 11,496.27 | ||
| EPS (TTM) (BDT) | 1.946 | ||
| Beta | 0 | ||
| Volatility % | 15.55 | ||
| 14-Day RSI | 60.21 | ||
| 14-Day ATR (BDT) | 3.348324 | ||
| 20-Day SMA (BDT) | 69.665 | ||
| 12-1 Month Momentum % | -19.1 | ||
| 52-Week Range (BDT) | 61.3 - 91.8 | ||
| Shares Outstanding (Mil) | 234 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orion Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orion Pharma Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orion Pharma Ltd Frequently Asked Questions
What is Orion Pharma Ltd(DHA:ORIONPHARM)'s stock price today?
The current price of DHA:ORIONPHARM is BDT74.80. The 52 week high of DHA:ORIONPHARM is BDT91.80 and 52 week low is BDT61.30.
When is next earnings date of Orion Pharma Ltd(DHA:ORIONPHARM)?
The next earnings date of Orion Pharma Ltd(DHA:ORIONPHARM) is .
Does Orion Pharma Ltd(DHA:ORIONPHARM) pay dividends? If so, how much?
The Dividend Yield %  of Orion Pharma Ltd(DHA:ORIONPHARM) is 1.34% (As of Today), Highest Dividend Payout Ratio of Orion Pharma Ltd(DHA:ORIONPHARM) was 0.53. The lowest was 0.25. And the median was 0.4. The  Forward Dividend Yield % of Orion Pharma Ltd(DHA:ORIONPHARM) is 1.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers